154 related articles for article (PubMed ID: 20927348)
1. Targeting the PI3K/Akt cell survival pathway to induce cell death of HIV-1 infected macrophages with alkylphospholipid compounds.
Lucas A; Kim Y; Rivera-Pabon O; Chae S; Kim DH; Kim B
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927348
[TBL] [Abstract][Full Text] [Related]
2. Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat.
Kim Y; Hollenbaugh JA; Kim DH; Kim B
PLoS One; 2011; 6(7):e21781. PubMed ID: 21765914
[TBL] [Abstract][Full Text] [Related]
3. Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy.
Chugh P; Bradel-Tretheway B; Monteiro-Filho CM; Planelles V; Maggirwar SB; Dewhurst S; Kim B
Retrovirology; 2008 Jan; 5():11. PubMed ID: 18237430
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rb1 eliminates HIV-1 (D3)-transduced cytoprotective human macrophages by inhibiting the AKT pathway.
Jeong JJ; Kim B; Kim DH
J Med Food; 2014 Aug; 17(8):849-54. PubMed ID: 24983400
[TBL] [Abstract][Full Text] [Related]
5. Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway.
Ruiter GA; Zerp SF; Bartelink H; van Blitterswijk WJ; Verheij M
Anticancer Drugs; 2003 Feb; 14(2):167-73. PubMed ID: 12569304
[TBL] [Abstract][Full Text] [Related]
6. Poligapolide, a PI3K/Akt inhibitor in immunodeficiency virus type 1 TAT-transduced CHME5 cells, isolated from the rhizome of Polygala tenuifolia.
Yoo SY; Le TK; Jeong JJ; Kim DH
Chem Pharm Bull (Tokyo); 2014; 62(5):467-71. PubMed ID: 24789928
[TBL] [Abstract][Full Text] [Related]
7. Anticancer mechanisms and clinical application of alkylphospholipids.
van Blitterswijk WJ; Verheij M
Biochim Biophys Acta; 2013 Mar; 1831(3):663-74. PubMed ID: 23137567
[TBL] [Abstract][Full Text] [Related]
8. Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells.
Su JS; Woods SM; Ronen SM
NMR Biomed; 2012 Feb; 25(2):379-88. PubMed ID: 22253088
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a small molecule agonist of phosphatidylinositol 3-kinase p110α that reactivates latent HIV-1.
Doyon G; Sobolewski MD; Huber K; McMahon D; Mellors JW; Sluis-Cremer N
PLoS One; 2014; 9(1):e84964. PubMed ID: 24489654
[TBL] [Abstract][Full Text] [Related]
10. Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.
Kondapaka SB; Singh SS; Dasmahapatra GP; Sausville EA; Roy KK
Mol Cancer Ther; 2003 Nov; 2(11):1093-103. PubMed ID: 14617782
[TBL] [Abstract][Full Text] [Related]
11. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.
Papa V; Tazzari PL; Chiarini F; Cappellini A; Ricci F; Billi AM; Evangelisti C; Ottaviani E; Martinelli G; Testoni N; McCubrey JA; Martelli AM
Leukemia; 2008 Jan; 22(1):147-60. PubMed ID: 17928881
[TBL] [Abstract][Full Text] [Related]
12. Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line.
Chugh P; Fan S; Planelles V; Maggirwar SB; Dewhurst S; Kim B
J Mol Biol; 2007 Feb; 366(1):67-81. PubMed ID: 17157319
[TBL] [Abstract][Full Text] [Related]
13. Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.
Mahmud J; Miller MJ; Altman AM; Chan GC
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493823
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.
van Montfort T; van der Sluis R; Darcis G; Beaty D; Groen K; Pasternak AO; Pollakis G; Vink M; Westerhout EM; Hamdi M; Bakker M; van der Putten B; Jurriaans S; Prins JH; Jeeninga R; Thomas AAM; Speijer D; Berkhout B
EBioMedicine; 2019 Apr; 42():97-108. PubMed ID: 30824386
[TBL] [Abstract][Full Text] [Related]
15. 5,7-Dihydroxy-6-Methoxy-Flavonoids Eliminate HIV-1 D3-transfected Cytoprotective Macrophages by Inhibiting the PI3K/Akt Signaling Pathway.
Jeong JJ; Kim DH
Phytother Res; 2015 Sep; 29(9):1355-1365. PubMed ID: 26096700
[TBL] [Abstract][Full Text] [Related]
16. Hitting HIV where it hides.
Dayton AI
Retrovirology; 2008 Feb; 5():15. PubMed ID: 18241337
[TBL] [Abstract][Full Text] [Related]
17. Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication.
Campbell GR; Bruckman RS; Herns SD; Joshi S; Durden DL; Spector SA
J Biol Chem; 2018 Apr; 293(16):5808-5820. PubMed ID: 29475942
[TBL] [Abstract][Full Text] [Related]
18. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism.
Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM
Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh1 eliminates the cytoprotective phenotype of human immunodeficiency virus type 1-transduced human macrophages by inhibiting the phosphorylation of pyruvate dehydrogenase lipoamide kinase isozyme 1.
Jeong JJ; Kim B; Kim DH
Biol Pharm Bull; 2013; 36(7):1088-94. PubMed ID: 23811558
[TBL] [Abstract][Full Text] [Related]
20. A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.
Kushner BH; Cheung NV; Modak S; Becher OJ; Basu EM; Roberts SS; Kramer K; Dunkel IJ
Int J Cancer; 2017 Jan; 140(2):480-484. PubMed ID: 27649927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
